Heparin-induced thrombocytopenia (HIT) in hemodialysis patients experienced in our hospital-Reference-Cited by-同舟云学术

Heparin-induced thrombocytopenia (HIT) in hemodialysis patients experienced in our hospital

Published:2013 Issue:11 Volume:46 Page:1075-1081
ISSN:1340-3451
Container-title:Nihon Toseki Igakkai Zasshi
language:en
Short-container-title:Nihon Toseki Igakkai Zasshi

Author:

Miyatomi Yoshiho¹,Inayama Emi²,Nagakura Kazutake¹,Shigeta Yasuhiro¹,Iwasaki Masashi³,Murakami Koichi³,Nagakawa Osamu⁴,Sakai Takehiko¹,Kono Takashi²,Ando Ken⁴,Shirai Koji¹,Masai Motoyuki¹,Yoshida Toyohiko¹

Affiliation:

1. Mihama Hospital

2. Mihama Narita Clinic

3. Mihama Katori Clinic

4. Mihama Sakura Clinic

Publisher

Japanese Society for Dialysis Therapy

Subject

Organic Chemistry,Biochemistry

Link

https://www.jstage.jst.go.jp/article/jsdt/46/11/46_1075/_pdf

Reference15 articles.

1. 1) Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992 ; 68 : 95-6.

2. 2) Yamamoto S, Koide M, Matsuo M, et al. Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 1996 ; 28 : 82-5.

3. 4) Rauova L, Zhai L, Kowalska MA, et al. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis : diagnostic and therapeutic implications. Blood 2006 ; 107 : 2346-53.

4. 5) Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retorospective analysis of 408 patients. Thromb Haemost 2005 ; 94 : 132-5.

5. 6) Warkentin TE, Sheppard JA, Horsewood P, et al. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000 ; 96 : 1703-8.